Navigation Links
InvivoSciences receives NIH grant for heart technology

Wauwatosa, Wis. - To perfect a technology that allows researchers to test new drugs on tiny rings of beating heart tissue, one needs money. And fortunately for one local company, the federal government is willing to absorb some of the cost of such an endeavor.

To improve its technology, InvivoSciences, LLC, a start-up biotechnology firm ......

Full article >>> or," was developed in collaboration with Middleton-based Gilson, Inc. It detects drug interactions with tissue that mimics healthy or diseased hearts. With this capability, some researchers could eliminate the need to test drugs on whole animals.

......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 10/27/06


Related biology technology :

1. Medical College receives $377K to study brain disease
2. Lucigen receives $750K grant to boost biofuel yields
3. Medical College receives $1.4M cancer grant
4. Wisconsin biotech firm receives $107K NIH grant
5. Medical College receives $11 million grant to study high blood pressure
6. Madison business receives $115,000 of new state biofuels funding
7. Superior receives funds for technical training
8. UWM receives state funding for plastics research
9. GEs Centricity EHR receives federal certification
10. WHIE receives state eHealth Initiative contract
11. SGI receives court approval for bankruptcy motions
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... 24, 2017 On Thursday, March ... at 5,817.69, down 0.07%; the Dow Jones Industrial Average ... S&P 500 closed at 2,345.96, marginally dropping 0.11%. US ... in green, 4 sectors finished in red, and 1 ... has initiated reports coverage on the following Biotechnology equities: ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... viscoelastic material that exhibits both viscous and elastic characteristics when deformed, which is ... polymer exhibits properties to gently absorb compressive forces and return to its natural ...
(Date:3/23/2017)... 2017  Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), ... for solid tumor cancers, today announced that yesterday ... announced last Friday, March 17, 2017. ... securities totaling 28,843,692 shares, comprised of 18,843,692 common ... of Class C Warrants pre-funded at the closing ...
(Date:3/23/2017)... MENLO PARK, Calif., March 23, 2017  BioPharmX ... developing products for the dermatology market, today reported ... Jan. 31, 2017, and will provide an update ... from the year. "We are pleased ... productive year for BioPharmX," said President Anja Krammer. ...
Breaking Biology Technology:
(Date:2/24/2017)... Spain , Feb. 24, 2017  EyeLock LLC, a ... demonstrate its elite iris biometric solution on the ... X16 LTE at Mobile World Congress 2017 ... Qualcomm,s Booth in Hall 3, Stand 3E10. ... the Qualcomm Haven™ security platform—a combination of ...
(Date:2/16/2017)... 2017  Genos, a community for personal genetic ... received Laboratory Accreditation from the College of American ... laboratories that meet stringent requirements around quality, accuracy ... "Genos is committed to maintaining the ... honored to be receiving CAP accreditation," said ...
(Date:2/10/2017)... DUBLIN , Feb 10, 2017 ... PharmaBiotech,s new report "Personalized Medicine - Scientific and Commercial ... ... in personalized medicine. Diagnosis is integrated with therapy for selection ... emphasis on early detection and prevention of disease in modern ...
Breaking Biology News(10 mins):